• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    J B Chemicals & Pharmaceuticals Ltd.
    01 Aug 2025
    Insider Trades
    1699.90
    -0.33%
    'Buy' JB Chemicals Maintains PL Capital Post Q1 Results Check Target Price
    'Buy' JB Chemicals Maintains PL Capital Post Q1 Results Check Target Price
    NDTV Profit
    JB Chemicals' margins will continue to improve beyond FY27 with grant of perpetual license of acquired opthal portfolio.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 319 to 311 in Jun 2025 qtr
    logo
    Gland Pharma Ltd.
    01 Aug 2025
    2021.20
    2.82%
    US tariffs call for strategic agility, cost discipline to ensure growth: Gland Pharma Executive Chairman Srinivas Sadu
    Business Line
    Gland Pharma is open to explore strategic M&As to access new technologies, diversify portfolio
    Copy LinkShare onShare on Share on Share on
    Gland Pharma Ltd.'s price crossed above 50Day SMA today
    logo
    Pfizer Ltd.
    01 Aug 2025
    5227.00
    1.15%
    Trump demands pharma companies slash US prices in blow to industry
    Business Standard
    In the letters, sent to Eli Lilly & Co., Novo Nordisk A/S, Pfizer Inc. and others, Trump insisted companies immediately lower what they charge Medicaid for existing drugs
    Copy LinkShare onShare on Share on Share on
    Pfizer Ltd. has gained 27.74% in the last 6 Months
    logo
    Pfizer Ltd.
    31 Jul 2025
    5227.00
    1.15%
    Trump Sets Sept 29 Deadline For J&J, Pfizer, Other Pharma Firms To Lower US Drug Prices
    Trump Sets Sept 29 Deadline For J&J, Pfizer, Other Pharma Firms To Lower US Drug Prices
    NDTV Profit
    Donald Trump, in his letter to big pharma company CEOs, has demanded "most-favored-nation" pricing for Medicaid.
    Copy LinkShare onShare on Share on Share on
    Pfizer Ltd.'s price crossed above 30Day SMA today
    logo
    Mankind Pharma Ltd.
    31 Jul 2025
    2579.60
    -0.75%
    Mankind Pharma Q1 PAT drops 17.4% despite 24% revenue growth, costs surge
    Business Standard
    Input and finance costs weigh on profitability; chronic, consumer health and BSV acquisition support top line
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 640 to 648 in Jun 2025 qtr.
    Mankind Pharma Q1 results: Profit dips 17% to 445 cr; revenue rises
    Business Standard | 31 Jul 2025 1 more
    Mankind Pharma Q1 Results: Profit Declines 18%, Revenue Up 25%
    NDTV Profit | 31 Jul 2025
    logo
    Aurobindo Pharma Ltd.
    31 Jul 2025
    1094.40
    -1.33%
    Lannett deal gives Aurobindo Pharma a strategic edge amid US tariff concerns
    Business Line
    The acquisition brings cost synergies, SG&A rationalisation, and access to government procurement programs due to the local footprint.
    Copy LinkShare onShare on Share on Share on
    Aurobindo Pharma Ltd.'s price crossed above 50Day SMA today
    logo
    Orchid Pharma Ltd.
    31 Jul 2025
    710.75
    0.70%
    Orchid Pharma hits 5% upper circuit in trade; why is the stock in demand?
    Business Standard
    Orchid Pharma shares were locked in a 5 per cent upper circuit at 740.1 per share on BSE; here's why
    Copy LinkShare onShare on Share on Share on
    Orchid Pharma Ltd. is trading below all available SMAs
    logo
    J B Chemicals & Pharmaceuticals Ltd.
    30 Jul 2025
    Insider Trades
    1699.90
    -0.33%
    JB Pharma Q1 results: Net profit up at 14% to 202 cr, revenue rises 9%
    Business Standard
    JB Chemicals & Pharmaceuticals Ltd on Wednesday reported a 14 per cent rise in net profit to Rs 202 crore in the June quarter. The company had posted a net profit of Rs 177 crore in the corresponding period of the previous fiscal year, JB Chemicals & Pharmaceuticals (JB Pharma) said in a regulatory filing. Revenue in the first quarter stood at Rs 1,094 crore as against Rs 1,004 crore in the same period a year ago, up 9 per cent, it added. "The domestic business recorded approximately 14 per cent value growth. This was driven by acute and chronic segments, including our ophthalmology portfolio. Our major brands & their franchises are also performing well," JB Pharma CEO and Wholetime Director, Nikhil Chopra said. He further said, "The CDMO (contract development and manufacturing organisation) business momentum is likely to sustain in coming quarters." The company said its domestic formulations business recorded revenue of Rs 678 crore as against Rs 595 crore in the first...
    Copy LinkShare onShare on Share on Share on
    J B Chemicals & Phar.. has an average target of 2030.00 from 2 brokers.
    logo
    Aurobindo Pharma Ltd.
    30 Jul 2025
    1094.40
    -1.33%
    Aurobindo Pharma to acquire US-based drug-makerLannett Company for 2185 cr
    Business Line
    Lannett has been is a US based manufacturer and supplier of superior quality, complex generic pharmaceuticals
    Copy LinkShare onShare on Share on Share on
    Aurobindo Pharma Ltd. has lost -27.40% in the last 1 Year
    logo
    Mankind Pharma Ltd.
    30 Jul 2025
    2579.60
    -0.75%
    Mankind Pharma Q1 Results Preview: Revenue Likely To Rise, Net Profit May Decline
    Mankind Pharma Q1 Results Preview: Revenue Likely To Rise, Net Profit May Decline
    NDTV Profit
    As per Bloomberg estimates, Mankind Pharma's consolidated revenue for the first quarter is expected to rise year-on-year to Rs 3,605.53 crore.
    Copy LinkShare onShare on Share on Share on
    Mankind Pharma Ltd. has an average target of 2840.50 from 2 brokers.
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd